MENU
+Compare
BSX
Stock ticker: NYSE
AS OF
Nov 13, 04:59 PM (EDT)
Price
$105.03
Change
+$0.90 (+0.86%)
Capitalization
154.37B

BSX Boston Scientific Corp Forecast, Technical & Fundamental Analysis

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts... Show more

BSX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for BSX with price predictions
Nov 12, 2025

BSX in upward trend: price rose above 50-day moving average on November 10, 2025

BSX moved above its 50-day moving average on November 10, 2025 date and that indicates a change from a downward trend to an upward trend. In of 43 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 11, 2025. You may want to consider a long position or call options on BSX as a result. In of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BSX just turned positive on November 10, 2025. Looking at past instances where BSX's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for BSX crossed bullishly above the 50-day moving average on November 11, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BSX advanced for three days, in of 352 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 394 cases where BSX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The 50-day moving average for BSX moved below the 200-day moving average on October 16, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BSX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BSX broke above its upper Bollinger Band on November 12, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock better than average.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BSX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.596) is normal, around the industry mean (63.534). P/E Ratio (55.684) is within average values for comparable stocks, (37.086). Projected Growth (PEG Ratio) (1.018) is also within normal values, averaging (1.687). BSX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (8.032) is also within normal values, averaging (79.919).

View a ticker or compare two or three
BSX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

BSX is expected to report earnings to rise 4.04% to 78 cents per share on February 04

Boston Scientific Corp BSX Stock Earnings Reports
Q4'25
Est.
$0.78
Q3'25
Beat
by $0.04
Q2'25
Beat
by $0.02
Q1'25
Beat
by $0.08
Q4'24
Beat
by $0.04
The last earnings report on October 22 showed earnings per share of 75 cents, beating the estimate of 70 cents. With 3.11M shares outstanding, the current market capitalization sits at 154.37B.
A.I. Advisor
published General Information

General Information

a maker of medical devices

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
300 Boston Scientific Way
Phone
+1 508 683-4000
Employees
48000
Web
https://www.bostonscientific.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IWDL46.842.09
+4.67%
ETRACS 2x Leveraged US Value Fctr TR ETN
NUKZ68.500.30
+0.44%
Range Nuclear Renaissance ETF
ACWI142.330.28
+0.20%
iShares MSCI ACWI ETF
MYCF25.07-0.02
-0.08%
SPDR SSGA My2026 Corporate Bond ETF
CVSB50.66-0.12
-0.23%
Calvert Ultra-Short Investment Grade ETF

BSX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BSX has been closely correlated with ISRG. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if BSX jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSX
1D Price
Change %
BSX100%
+1.59%
ISRG - BSX
71%
Closely correlated
+0.05%
SYK - BSX
65%
Loosely correlated
+1.00%
MMSI - BSX
56%
Loosely correlated
-1.42%
EW - BSX
51%
Loosely correlated
+0.49%
ALC - BSX
49%
Loosely correlated
+2.69%
More

Groups containing BSX

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSX
1D Price
Change %
BSX100%
+1.59%
BSX
(3 stocks)
77%
Closely correlated
+0.45%
Medical/Nursing Services
(215 stocks)
58%
Loosely correlated
-2.32%
Health Services
(422 stocks)
-5%
Poorly correlated
-2.10%